Journal of Pediatric Health Care
Volume 20, Issue 5 , Pages 342-349 , September 2006

Educating Teens About Vaccines

References 

  1. ACOG Committee on Adolescent Health Care . Committee opinion: Meningococcal vaccination for adolescents . Obstetrics & Gynecology . 2005;106:667–669
  2. American Academy of Pediatrics Committee on Infectious Diseases . Prevention and control of meningococcal disease: Recommendations for use of meningococcal vaccines in pediatric patients . Pediatrics . 2005;116:496–505
  3. American Academy of Pediatrics Committee on Infectious Diseases . Policy statement: Recommended childhood and adolescent immunization schedule—United States, 2006 . Pediatrics . 2006;117:239–240
  4. Arvin A , Greenberg H . New viral vaccines . Virology . 2005;344:240–249
  5. Bonnez W . Immunization against genital human papillomavirus . The Pediatric Infectious Disease Journal . 2005;24:1005–1006
  6. Centers for Disease Control and Prevention . National, state and urban area vaccination coverage among children aged 19-35 months: United States, 2003 . MMWR: Morbidity and Mortality Weekly Review . 2004;53:658–661
  7. Centers for Disease Control and Prevention . Notice to readers: Licensure of a combined live attenuated measles, mumps, rubella, and varicella vaccine . MMWR: Morbidity and Mortality Weekly Review . 2005;54:1212–1215
  8. Centers for Disease Control and Prevention . Vaccines for children program: Vaccines to prevent measles, mumps, rubella, and varicella . Atlanta, GA: Advisory Committee on Immunization Practices; 2005; Retrieved May 23, 2006, from the Centers for Disease Control and Prevention Web site: www.cdc.gov
  9. Centers for Disease Control and Prevention . Genital HPV infection fact sheet . Atlanta, GA: CDC National Prevention Information Network; 2006; Retrieved May 23, 2006, from the Centers for Disease Control and Prevention Web site: www.cdc.gov
  10. Centers for Disease Control and Prevention . Recommended childhood and adolescent immunization schedule--United States, 2006 . MMWR Weekly . 2006;54(52):Q1–Q4 Retrieved March 4, 2006, from the Centers for Disease Control and Prevention Web site: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5451-Immunizational.htm?s_cid=mm5
  11. Cohen AC , Broder KR , Pickering LK . Immunizations in the United States: A rite of passage . Pediatric Clinics of North America . 2005;52:669–693
  12. Committee of Infectious Diseases . Policy statement: Prevention of pertussis among adolescents: Recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine . Pediatrics . 2006;117:965–978
  13. Dempsey A , Zimet G , Davis R , Koutsky L . Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV . Pediatrics . 2006;117:1486–1493
  14. Food and Drug Administration . FDA licenses quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil) for the prevention of cervical cancer and other diseases in females caused by human papillomavirus. FDA Center for Drug Evaluation and Research . 2006; Retrieved August 2, 2006, from the Food and Drug Administration Website: www.fda.gov/cder/Offices/OODP/gardasil.htm
  15. Food and Drug Administration . Product approval information: Licensing action. FDA Center for Drug Evaluation and Research . 2006; Retrieved August 2, 2006, from the Food and Drug Administration Website: www.fda.gov/cder/label/hpvmer060806LB.htm
  16. Guinto-Oampo H , McNeil BK , Aronoff SC . Pertussis . 2006; Retrieved May 27, 2006, from the eMedicine Web site: http://www.emedicine.com/ped/topic1778.htm
  17. Harper D, Franco E, Wheeler C, Moscicki A, Romanowski B, Roteli-Martins C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomized controlled trial . Lancet . 2004;364:1757–1765
  18. Harper D, Franco E, Wheeler C, Moscicki A, Romanowski B, Roteli-Martins C, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomized control trial . Lancet . 2006;367:1247–1255
  19. Humiston SG , Rosenthal SL . Challenges to vaccinating adolescents-Vaccine implementation issues . The Pediatric Infectious Disease Journal . 2005;24(Suppl.):S134–S140
  20. Knuf M, Habermehl P, Zepp F, Mannhardt W, Kuttnig M, Muttonen P, et al. Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children . The Pediatric Infectious Disease Journal . 2006;25:12–18
  21. Morantz C . Practice guidelines: ACIP updates recommendations for prevention of hepatitis B virus transmission . American Family Physician . 2006;73:1839–1847
  22. Nguyen H , Jumaan A , Seward J . Decline in mortality due to varicella after implementation of varicella vaccination in the United States . New England Journal of Medicine . 2005;352:450–458
  23. Nolan T , McIntyre P , Roberton D , Descamps D . Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine . Vaccine . 2002;21:281–289
  24. Olshen E , Woods E , Austin A , Luskin M , Bauchner H . Parental acceptance of the human papillomavirus vaccine . Journal of Adolescent Health . 2005;37:248–251
  25. Shinefield H, Black S, Williams WR, Marchant C, Reisinger K, Stewart T, et al. Dose-response study of a quadrivalent measles, mumps, rubella, and varicella vaccine in healthy children . The Pediatric Infectious Disease Journal . 2005;24:670–675
  26. Shinefield H, Black S, Digilio L, Reisinger K, Blatter M, Gress JO, et al. Evaluation of a quadrivalent measles, mumps, rubella, and varicella vaccine in healthy children . The Pediatric Infectious Disease Journal . 2005;24:665–669
  27. Shinefield H , Black S , Staehle B , Matthews H , Adelman T , Ensor K . Vaccination with measles, mumps, and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody, and duration of protection against varicella in healthy children . The Pediatric Infectious Disease Journal . 2002;21:555–561
  28. Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, et al. Prophylactic quadrivalent human papillomavirus (types 6,11,16,and 18) L1 virus-like particle vaccine in young women: A randomized double-blind placebo-controlled multicentre phase II efficacy trial . Lancet Oncology . 2005;6:271–278
  29. Williamson A , Passmore J , Rybicki A . Strategies for the prevention of cervical cancer by human papillomavirus vaccination . Clinical Obstetrics & Gynecology . 2005;19:531–544
  30. Yu AS , Cheung RC , Keefe EB . Hepatitis B vaccines . Infectious Disease Clinics of North America . 2006;20:27–45
  31. Zimet G . Improving adolescent health: focus on HPV vaccine acceptance . Journal of Adolescent Health, 37 . 2005;S17–S23

PII: S0891-5245(06)00415-9

doi: 10.1016/j.pedhc.2006.07.002

Journal of Pediatric Health Care
Volume 20, Issue 5 , Pages 342-349 , September 2006

Article Tools

* Image Usage & Resolution